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Introduction 
Angioimmunoblastic T-cell lymphoma (AITL) was 
first described in 1974 [1] as a non-neoplastic 
hematologic condition with a propensity for skin 
manifestations. Now known as an aggressive 
peripheral T-cell lymphoma with high mortality, AITL 
comprises 1-2% of non-Hodgkin lymphoma cases [2]. 
Cutaneous manifestations are frequent in AITL and 
may precede systemic symptoms [3]. In a 
retrospective study of 52 patients with newly 
diagnosed AITL, 15 patients had skin manifestations 
at diagnosis [4]. We report two additional patients in 
which cutaneous manifestations preceded the 
diagnosis of AITL: one patient with large vasculitic 
ulcers accompanied by constitutional symptoms and 
a neck mass, and a second patient presenting with a 
diffuse urticarial eruption and lymphadenopathy. 
 
Case Synopsis 
Patient 1 
A 54-year-old woman presented with fatigue, 
malaise, swollen and painful lower legs, oral ulcers, 
and a neck mass. She was admitted for further 
workup and a few days after admission developed a 
petechial rash with dermal nodules and retiform 
purpura on her lower extremities, which 
subsequently coalesced into weeping, necrotic 
ulcers (Figure 1A). A computerized tomography 
scan of the chest showed bilateral axillary, hilar, and 
mediastinal lymphadenopathy and she was 
Abstract 
Angioimmunoblastic T-cell lymphoma (AITL) is a rare 
form of non-Hodgkin lymphoma often accompanied 
by autoimmune and paraneoplastic phenomena. Up 
to 50% of patients with AITL present with skin 
manifestations. This case series highlights two cases 
of AITL presenting with unusual cutaneous findings: 
one with a medium-vessel vasculitis and another 
with a chronic urticarial eruption. Clinicians should 
consider AITL in the differential diagnosis of vasculitis 
or urticaria refractory to standard treatment. 
Figure 1 A) Patient 1 with necrotic leg ulcers upon presentation. 
B) Marked healing of leg ulcers in Patient 1. 
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transferred to a regional medical center for specialty 
oncology care. 
Laboratory data showed a total white blood cell 
count of 2,490 cells/μL, absolute neutrophil count of 
770 cells/μL, hematocrit of 23.2%, and platelets of 
200,000 cells/μL. The erythrocyte sedimentation rate 
and C-reactive protein were elevated at 76mm/hr 
and 79. 4mg/L, respectively, whereas complement 
levels (C3 and C4) were low. Skin biopsy from the 
right lower leg showed epidermal necrosis, 
superficial and deep perivascular infiltrate of 
lymphocytes, plasma cells and neutrophils, and small 
to medium vessel vasculitis, with vessel wall necrosis 
and fibrin deposition in the upper dermis (Figure 2). 
Axillary lymph node biopsy revealed atypical 
infiltrating CD2, CD3, and CD5 positive lymphocytes, 
with partial loss of CD7 and PD1, and rare weakly-
positive cells by Epstein Barr virus (EBV) in situ 
hybridization. T-cell receptor gene rearrangement 
PCR studies demonstrated a clonal T-cell population 
in the lymph node, further supporting a T-cell 
lymphoma. 
Based on the combination of lymph node and bone 
marrow findings, the patient was diagnosed with 
stage III AITL, high risk (age-adjusted international 
prognostic index), [5], with associated 
paraneoplastic vasculitis. She was initially treated 
with prednisone (1mg/kg) and began dose-adjusted 
EPOCH (etoposide, prednisone, cyclophosphamide, 
vincristine, doxorubicin omitted) combination 
chemotherapy for a total of 5 cycles. Wound care 
with compression and sharp debridement of the 
necrotic eschar was initiated. Within a few months of 
starting chemotherapy and meticulous wound care, 
the patient had marked healing of her wounds 
(Figure 1B) and underwent autologous stem cell 
transplant. However, 24 months later she had relapse 
of her AITL and died. 
Patient 2 
A 62-year-old woman presented with a four-month 
history of an urticarial eruption, cervical 
lymphadenopathy, weight loss, night sweats, and 
fevers. An allergy consultant suggested viral 
infection triggering urticaria; she had minimal 
improvement with a prednisone taper. Physical 
examination showed irregularly-shaped, well-
demarcated, edematous plaques on her lower 
extremities and back (Figure 3), as well as cervical 
and axillary lymphadenopathy. Punch biopsies from 
the urticarial plaques showed mixed inflammatory 
dermal infiltrate composed of lymphocytes, 
eosinophils, plasma cells, and rare neutrophils 
(Figure 4). Tissue flow cytometry from the skin was 
negative for an atypical population. 
Three days after dermatologic evaluation, the 
patient was admitted to the hospital for an 
expedited workup. Respiratory viral studies were 
negative. Laboratory testing showed normal 
Figure 2. Skin biopsy taken from lower anterior shin of Patient 1, demonstrating medium vessel vasculitis, with thickening and fibrin 
deposition, neutrophils and leukocytoclastic debris in vessel walls. H&E, 1.25×, and 20×. 
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complete blood count, normal erythrocyte 
sedimentation rate, and C-reactive protein elevation 
to 115.8mg/L. Axillary lymph node biopsy revealed 
an abnormal T-cell population expressing CD3, 
CD10, Bcl6, and PD1; CD2 and CD5 were normal. 
Epstein Barr virus in situ hybridization was positive in 
individual cells admixed with the T-cells. T-cell 
receptor gene rearrangement studies demonstrated 
a clonal T-cell population by PCR. PET-CT showed 
lymphadenopathy above and below the diaphragm 
and the patient was diagnosed with Stage IIIB AITL, 
high grade (International prognostic index), [6]. She 
was initiated on CEOP combination chemotherapy 
and received topical triamcinolone and oral 
hydroxyzine for symptomatic control of urticarial 
eruption. She was discharged from the hospital and 
readmitted 12 days later with progressive rash, 
lymphadenopathy, and neutropenic fever attributed 
to malignancy after negative infectious workup. The 
patient was switched to BeGeV (bendamustine, 
gemcitabine, vinorelbine) combination chemotherapy, 
with resolution of her fever and urticarial dermatosis 
after cycle 1. The patient remains on a treatment 
holiday without lymphoma progression. 
 
Case Discussion 
Since its initial description over 40 years ago, the 
understanding of AITL has evolved from a benign 
reactive condition to a CD4+, CD8- peripheral T-cell 
lymphoma with prominent dysregulation of 
endothelial and B-cells. Angioimmunoblastic T-cell 
lymphoma is believed to initiate within EBV-infected 
B-cells, which proliferate after genetic 
rearrangement and clonal expansion. Survival of 
these EBV-infected B-cells likely results in stimulation 
of dendritic follicular T-helper cells, resulting in 
malignant transformation of the T-cells [7]. 
Skin manifestations are the presenting sign of AITL in 
40-50% of patients [1-4, 7, 8], with a non-specific 
morbilliform eruption mimicking viral exanthem or 
drug eruption most commonly described [8]. Over 
half of patients with AITL-associated rash report 
pruritus [2]. This presents a diagnostic challenge in 
AITL owing to common misdiagnosis and 
subsequent delayed treatment of AITL. Other skin 
manifestations reported in association with AITL 
include nodules, erythroderma, and annular rash. 
Vasculitis was found in 12% of patients with AITL in 
77 cases reviewed by Lachenal et al. [2]. The vasculitis 
associated with AITL has primarily been described as 
small vessel leukocytoclastic vasculitis [10, 11]. 
However, there are rare reports of patients 
presenting with cutaneous medium vessel vasculitis 
[1, 9, 13]. Paraneoplastic vasculitis occurs owing to 
antigen production resulting in increased immune 
complex deposition. Increased inflammatory 
mediators (e.g., interferon gamma, interleukins 6 and 
12, TNF-alpha) and increased coagulation and 
angiogenesis are also believed to contribute [13]. 
There are a few reports of patients with AITL 
presenting with chronic urticarial eruptions [2, 3]. It 
has been suggested that infiltrating T-cells of the 
skin cause chronic urticaria through local release of 
 
Figure 3. Urticarial eruption of Patient 2 on presentation. 
Figure 4. Histopathology of punch biopsy taken from left hip of 
Patient 2, demonstrating a superficial perivascular inflammatory 
infiltrate with numerous eosinophils, and no evidence of 
vasculitis. (H&E, 4× and 40×). 
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vasoactive molecules in AITL [3]. Lack of response to 
antihistamines and corticosteroids (topical or 
systemic) may be a clue to diagnosis. Beyond these 
general tenants, the pathophysiological mechanism 
of urticarial eruption in AITL remains largely 
unknown [14]. 
 
Conclusion 
In summary, we report two patients presenting with 
atypical skin manifestations of AITL. One patient 
exhibited with a medium vessel paraneoplastic 
vasculitis and the second patient presented with a 
chronic urticarial eruption. Dermatologists should be 
aware of AITL as a rare, EBV-associated T-cell 
malignancy with a propensity for skin manifestations 
and should consider paraneoplastic vasculitis and 
urticaria related to AITL in their differential diagnosis. 
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